Exclusive interview with Pfizer CEO Albert Bourla as the company files for emergency use authorization for its COVID-19 ...

The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.

Pfizer Inc. is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire ...

Pfizer CEO Albert Bourla called vaccine skepticism in the highest levels of the federal government “an anomaly” during an investor call on Tuesday. “We will continue investing in vaccines because, as ...